INFECTIOUS DISEASE QUALITY CONTROLS

A broad selection of controls designed to monitor assay precision of hepatitis, retrovirus, sexually transmitted disease, congenital disease, and other infectious disease testing.

Select groups

1.1 Syphilis Control   »
1.2 Infectious disease   »
1.3 Hepatitis Control   »
1.4 Negative Basematrix   »
1.5 Panels & Interferences   »
1.6 All Virus Negative Control   »
1.7 TOR Ch IgG Control   »
1.8 Torch IgM Control   »
1.9 Zika / Dengue Control   »



1.1 Syphilis Control

Anti-Treponema Positive Control is confirmed reactive with multiple industry standard systems.



1.2 Infectious disease

Positive Control with multiple industry standard systems.
Both negative/positive and multianalyte controls.

Specificity   Specificity
BORRELIA IgM   MUMPS IgG
BORRELIA IgG   MYCOPLASMA IgG
CHAGAS   MYCOPLASMA IgM
CMV IgG   PARVOVIRUS B 19 IgM
CMV IgG Avidity   PARVOVIRUS B19 IgG
CMV IgM   RUBELLA IgG
EA IgG   RUBELLA IgM
EBNA IgG   SYPHILIS
EBV   TOXO IgG
EBV IgM   TOXO IgG Avidity
HAV IgM   TOXO IgM
HIV Ag / Ab Combo   TREPONEMA
HTLV-I / HTLV-II   VCA IgG
MEASLES IgG   Zika IgM
  • Liquid ready-to-use
  • Stable to expiry when stored at 2-8°C
  • Qualitative or quantative results



1.3 Hepatitis Control

HepCon I HepCon II HepCon III
Anti-HAV Anti-HAV Anti-CMV
HBc-IgM Anti-HBs Anti-HBc
HAV-IgM Anti-HBe Anti-HCV
  Anti-HBc Anti-HIV-1
    Anti-HTLV-I
    HBsAg
  • True human serum based
  • 3 year shelf life at 2–8ºC
  • 60 day open-vial stability at 2–8ºC



1.4 Negative Basematrix

Made from true human plasma & serum, Customized chemical profiles, batch size 1L - 1000L, 0.2μ filtered.

Code Specificity Form
SP0520 anti-HBs neg defibrinated
SP0521 anti-HAV neg delipidized
SP0830 Human Serum, anti-HBs neg. defibrinated
SP1846 IgG free delipidized
SP1848 Heavy charcoal stripped delipidized
SP1850 Estradiol (E2) free delipidized
SP1855 Steroid free delipidized
SP1904 All Hepatitis free defibrinated
SP1845 TSH affinity stripped delipidized



1.5 Panels & Interferences

Natural Interferences in EDTA plasma, serum or any other Matrix

Endogenous interference Optimal interfering concentration
Albumin 60 g/L
Bilirubin (unconjugated) 350 μmol/L
Bilirubin (conjugated) 350 μmol/L
Hemoglobin 2 g/L
Human DNA 0.4 mg/dl
Triglycerides 3000 mg/dl
  • Other Interferences: Systemic Lupus Erythematodis (SLE), Rheumatoid Factor (RF) / CCP, Antinuclear Antibody (ANA), HAMA, Rubella, Medications



1.6 Negative Basematrix

An non-reactive quality control, made from human serum. Non-reactive for tested analytes for Hepatitis, Retrovirus, Syphilis and antibodies to CMV

Anti-CMV Anti-HCV HAV-IgM
Anti-HAV Anti-HDV HIV-1 Ag
Anti-HBc Anti-HIV-1 Non-treponemal Antibodies
Anti-HBe Anti-HIV-2 (Syphilitic Reagin)
Anti-HBs Anti-HTLV-I Treponema pallidum
HBc-IgM Anti-HTLV-II (Syphilis) IgG
HBeAg   Treponema pallidum
HBsAg   (Syphilis) IgM



1.7 TORCH IgG Control

Two level, liquid control used to monitor the most widely used serology test methods. A positive and a negative control allow you to check the precision of your test system.

Liquid or lyophilized , human serum based

  • Toxoplasma gondii IgG
  • Rubella Virus IgG
  • Cytomegalovirus (CMV) IgG
  • Herpes Simplex Virus Type 1 (HSV-1) IgG
  • Herpes Simplex Virus Type 2 (HSV-2) IgG
  • Epstein-Barr Virus (VCA) IgG
  • Varicella Zoster Virus (VZV) IgG
  • Helicobacter pylori IgG
  • Treponema pallidum (Syphilis) IgG
  • Syphilis RPR
  • Open vial: 90 days at +2 ~ +8ºC
  • Closed vial: 3 years at +2 ~ +8ºC



1.8 TORCH IgM Control

Two level, unassayed liquid control used to monitor the precision of immunoassay methods to detect IgM antibodies to ToRCH panel analytes.

  • Toxoplasma gondii IgM
  • Rubella Virus IgM
  • Cytomegalovirus (CMV) IgM
  • Herpes Simplex Virus Type 1 (HSV-1) IgM
  • Herpes Simplex Virus Type 2 (HSV-2) IgM
  • Open vial: 90 days at +2 ~ +8ºC
  • Closed vial: 3 years at +2 ~ +8ºC



1.9 Zika / Dengue Control